| 1 Esteva FJ,Cheli CD,Fritsche H,et al.Clinical utility of serum HER-2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies[J].Breast Cancer Res,2005, 7(4):436-443.
2 Spatz A,Borg C,Feunteun J.X-Chromosome genetics and human cancer[J]. Cancer,2004,4(8):617-629.
3 Peters MA,Jarvik GP,Janer M,et al.Genetic linkage analysis of prostate cancer families to Xq27-28[J].Human Heredity,2001,51(1-2):107-113.
4 Choi C,Cho S,Horikawa I,et al.Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas[J].Genes Chromosomes Cancer,1997,20(3):234-242.
5 Choi C,Kim MH,Juhng SW.Loss of heterozygosity on chromosome XP22.2- p22.13 and Xq26.l-q27.1 in human breast caicinomas[J].J Korean Med Sci, 1998,13(3):311-316.
6 Piao Z,Malkhosyan SR.Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis[J].Cancer,2002,33(3):262-269.
7 Zuo T,Wang L,Morrison C,et al.FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene[J].Cell, 2007,129(7):1275-86.
8 Seton-Rogers S.Breast cancer;X-linked tumour suppression[J].Nature Reviews Cancer,2007,7:568-569.
9 Erikson E and Mailer JL.A protein kinase from Xenopus eggs specific for ribosomal protein S6[J].PNAS,1985,82(3):3742-46.
10 Rouxl PP,Shahbazian D,Vu H,et al.RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation[J].J Biol Chem,2007,282(19):14056-64.
11 Alcorta DA,Crews CM,Sweet LJ,et al.Sequence and expression of chicken and mouse rsk;homologs of Xenopus laevis ribosomal S6 kinase[J],Mol Cell Biol,1989,9(9):3850-59.
12 Anjum R,Blenis J.The RSK family of kinases;emerging roles in cellular signalling [J].Nat Rev Mol Cell Biol,2008,9(10):747-758.
13 Dummler BA,Hauge C,Silber J,et al.Functional characterization of human RSK4,a new 90-kDa ribosomal S6 kinase,reveals constitutive activation in most cell types[J].J Biol Chem,2005,280(14):13304-14.
14 Frodin M,Gammeltoft S.Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction[J].Mol Cell Endocrinol,1999,151(1-2):65- 77.
15 Clark DE,Errington TM,Smith JA,et al.The serine/threonine protein kinase, p90 ribosomal S6 kinase,is an important regulator of prostate cancer cell proliferation [J].Cancer Res,2005,65(8):3108-16.
16 Myers AP,Corson LB,Rossant J,et al.Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signal-regulated kinase signaling [J].Mol Cell Biol,2004,10(24):4255-66.
17 Berns K,Hijmans EM,Mullenders J,et al.A large-scale RNAi screen in human cells identifies new components of the p53 pathway[J].Nature,2004,428 (6981):431-437.
18 Thakur A,Xu H,Wang Y,et al.The role of X-linked genes in breast cancer [J].Breast Cancer Res Treat,2005,93(2):135-143.
19 Thakur A,Yuan Sun,Aliccia Bollig,et al.Anti-invasive and Antimetastatic Activities of Ribosomal Protein S6 Kinase 4 in Breast Cancer Cells[J].Clin Cancer Res,2008,14(14):4427-36.
20 Choi YH,Choi BT,Lee WH,et al.Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells[J].Oncol Rep,2001,8 (5):1091-96.
21 Musgrove EA,Lee CS,Cornish AL,et al.Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin -dependent kinase inhibitor p21[J].Mol Endocrinol,1997,11(1):54-66.
22 Kato M,Kitayama J,Kazama S,et al.Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma [J].Breast Cancer Res,2003,5(5):144-150.
23 Muller A,Homey B,Soto H,et al.Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,410(6824):50-56.
24 Hoevel T,Macek R,Mundigl O,et al.Expression and targeting of the tight junction protein CLDN1 in CLDN1 -negative human breast tumor cells[J],J Cell Physiol,2002,191(1):60-68.
25 Offner S,Hekele A,Teichmann U,et al.Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy[J].Cancer Immunol Immunother, 2005,54(5):431-445.
26 Hogdall EV,Ryan A,Kjaer SK,et al.Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma:from the Danish“MALOVA”OvarianCarcinomaStudy[J].Cancer,2004,1009(11):2387- 95.
27 Edelmann J,Richter K,H? nel C,et al.X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinoma[J].Int J Gynecol Cancer,2006,16(3):1248-53.
28 Park SC,Hwang UK,Ahn SH,et al.Genetic changes in bilateral breast cancer by comparative genomic hybridisation Xq21[J],Clin Exp Med,2007,7(1):1- 5.
29 Thakur A,Rahman KW,Wu J.Aberrant expression of x-linked genes rbAp46, RSK4,and Cldn2 in breast cancer[J].Mol Cancer Res,2007,5(2):171-181. |
